Furthermore, EMP1 has been shown in several studies to be a reliable biomarker in cancers such as gastric [51], colorectal [52] ovarian [53], bladder urothelial carcinoma [54] and non-small lung carcinoma [55]. Here, EMP1 is linked to bladder transitional cell carcinoma.